Keyphrases
Inflammatory Bowel Disease
100%
Crohn's Disease
96%
Exclusive Enteral nutrition
57%
Pediatric Inflammatory Bowel Disease
53%
Ulcerative Colitis
26%
COVID-19 Pandemic
22%
Microbiota
19%
Microbiome
19%
Fecal Calprotectin
19%
Active Crohn's Disease
17%
Celiac Disease
16%
Paediatric Gastroenterology
15%
Gut Microbiome
15%
Scotland
14%
Pediatric Patients
14%
Gut Microbiota
14%
Pediatric Crohn's Disease
14%
Fecal Microbiota Transplantation
13%
British Society
13%
Pediatric
13%
Infliximab
13%
Crohn's
12%
Campylobacter Concisus
12%
Remission
12%
Helicobacter Pylori (H. pylori)
10%
Adaptation
10%
Gastrointestinal Diseases
10%
COVID-19
9%
Gluten-free Diet
9%
Gastroenterology & Hepatology
9%
National Cohort Study
9%
Colitis
9%
Enterohemorrhagic Escherichia Coli
8%
Diet Therapy
8%
Fecal Samples
8%
Clinical Remission
8%
Healthy Controls
8%
Food Reintroduction
8%
Biosimilar Infliximab
8%
Ferric Carboxymaltose
8%
Colorectal Cancer
8%
Anti-tumor Necrosis Factor (anti-TNF)
8%
Treatment Outcome
8%
COVID-19 Impact
8%
Comparative Genomics
8%
Fecal Microbial
8%
Pediatric Hepatology
7%
Pediatric nutrition
7%
Gastrointestinal Tract
7%
Scottish
7%
Medicine and Dentistry
Inflammatory Bowel Disease
89%
Pediatrics
83%
Crohn's Disease
75%
Enteric Feeding
42%
COVID-19
28%
Disease
28%
Ulcerative Colitis
18%
Pediatric Gastroenterology
18%
Microbiome
16%
Faecal Calprotectin
14%
Pediatrics Patient
14%
Cohort Analysis
13%
Tumor Necrosis Factor
12%
Systematic Review
12%
Colitis
11%
Hepatology
10%
Patient with Crohn's Disease
10%
Infusion
10%
Gut
9%
Gut Microbiota
9%
Infection
9%
Pediatric Nutrition
9%
Diet Therapy
8%
Fecal Microbiota Transplantation
8%
Ferric Carboxymaltose
8%
Escherichia coli
8%
Coeliac Disease
8%
Inflammatory Bowel Disease
8%
Gut Microbiome
8%
Biological Product
7%
Infliximab
7%
Patient with Inflammatory Bowel Disease
7%
Helicobacter Pylori
6%
Propionic Acid
5%
Metagenome
5%
Biological Marker
5%